VERA THERAPEUTICS INC (VERA) Institutional Ownership Changes & 13F Activity
VERA THERAPEUTICS INC (VERA). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q4 2025). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Avoro Capital Advisors Llc, Price T Rowe Associates Inc, Deerfield Management Company, L.P., Kynam Capital Management, Lp, and Eversept Partners, Lp.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Ensign Peak Advisors, Inc | Sell | -6,700 | -72.0% | 2,600 | $131.66K | Q4 2025 | Aug 18, 2026 |
| Algert Global Llc | Sell | -228,520 | -77.9% | 64,868 | $3.28M | Q4 2025 | Aug 11, 2026 |
| Virtu Financial Llc | Buy | +5,870 | — | 5,870 | $297.00K | Q4 2025 | Feb 23, 2026 |
| Raymond James Financial Inc | Buy | +64,875 | — | 64,875 | $3.29M | Q4 2025 | Feb 18, 2026 |
| Kvp Capital Advisors, Lp | Buy | +32,700 | — | 32,700 | $1.66M | Q4 2025 | Feb 18, 2026 |
| Avoro Capital Advisors Llc | Buy | +5,888,888 | — | 5,888,888 | $298.21M | Q4 2025 | Feb 17, 2026 |
| Price T Rowe Associates Inc | Buy | +5,461,976 | — | 5,461,976 | $276.60M | Q4 2025 | Feb 17, 2026 |
| Deerfield Management Company, L.P. | Buy | +4,059,695 | — | 4,059,695 | $205.58M | Q4 2025 | Feb 17, 2026 |
| Kynam Capital Management, Lp | Buy | +3,433,051 | — | 3,433,051 | $173.85M | Q4 2025 | Feb 17, 2026 |
| Eversept Partners, Lp | Buy | +3,072,304 | — | 3,072,304 | $155.58M | Q4 2025 | Feb 17, 2026 |
| Fmr Llc | Buy | +2,885,853 | — | 2,885,853 | $146.14M | Q4 2025 | Feb 17, 2026 |
| Integral Health Asset Management, Llc | Buy | +1,800,000 | — | 1,800,000 | $91.15M | Q4 2025 | Feb 17, 2026 |
| Point72 Asset Management, L.P. | Buy | +1,738,385 | — | 1,738,385 | $88.03M | Q4 2025 | Feb 17, 2026 |
| Bellevue Group Ag | Buy | +1,698,152 | — | 1,698,152 | $85.99M | Q4 2025 | Feb 17, 2026 |
| Holocene Advisors, Lp | Buy | +1,307,393 | — | 1,307,393 | $66.21M | Q4 2025 | Feb 17, 2026 |
| Alliancebernstein L.P. | Buy | +1,218,657 | — | 1,218,657 | $61.71M | Q4 2025 | Feb 17, 2026 |
| Woodline Partners Lp | Buy | +1,000,279 | — | 1,000,279 | $50.65M | Q4 2025 | Feb 17, 2026 |
| First Light Asset Management, Llc | Buy | +869,676 | — | 869,676 | $44.04M | Q4 2025 | Feb 17, 2026 |
| Tri Locum Partners Lp | Buy | +805,689 | — | 805,689 | $40.80M | Q4 2025 | Feb 17, 2026 |
| Braidwell Lp | Buy | +784,742 | — | 784,742 | $39.74M | Q4 2025 | Feb 17, 2026 |
| Citadel Advisors Llc | Buy | +777,488 | — | 777,488 | $39.37M | Q4 2025 | Feb 17, 2026 |
| Bank Of America Corp | Buy | +694,319 | — | 694,319 | $35.16M | Q4 2025 | Feb 17, 2026 |
| Armistice Capital, Llc | Buy | +653,796 | — | 653,796 | $33.11M | Q4 2025 | Feb 17, 2026 |
| Rock Springs Capital Management Lp | Buy | +568,579 | — | 568,579 | $28.79M | Q4 2025 | Feb 17, 2026 |
| Vestal Point Capital, Lp | Buy | +550,000 | — | 550,000 | $27.85M | Q4 2025 | Feb 17, 2026 |
| Elmind Capital, Lp | Buy | +482,500 | — | 482,500 | $24.43M | Q4 2025 | Feb 17, 2026 |
| Northern Trust Corp | Buy | +473,219 | — | 473,219 | $23.96M | Q4 2025 | Feb 17, 2026 |
| Qube Research & Technologies Ltd | Buy | +378,055 | — | 378,055 | $19.14M | Q4 2025 | Feb 17, 2026 |
| Frontier Capital Management Co Llc | Buy | +371,151 | — | 371,151 | $18.80M | Q4 2025 | Feb 17, 2026 |
| Orbimed Advisors Llc | Buy | +353,500 | — | 353,500 | $17.90M | Q4 2025 | Feb 17, 2026 |
Frequently asked questions about VERA activity
Which institutional owners are buying VERA?
Institutional owners buying VERA include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in VERA activity?
"Buy" means an investor increased their reported position in VERA compared to the prior reporting period. This reflects growing exposure to VERA THERAPEUTICS INC (VERA) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in VERA increasing?
Institutional interest in VERA can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related VERA Institutional Insights
- VERA Overview
- VERA 13F Institutional Holders
- VERA Superinvestors
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- VERA Insider Trading & SEC Form 4 Activity
- VERA Articles
- Top Institutional Investor Stock Rankings